Somatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 4.
Figure 4.

Neurodevelopmental genes are recurrently targeted by structural variations in neuroblastoma. (AC) Function enrichment analysis bar plots for genes recurrently altered based on breakpoint analyses: (A) SJ-BPs; (B) RD-BPs; (C) CN-BPs. Analysis includes gene sets associated with diseases (green), Gene Ontology (purple), and Pathways (red). (D,E) Gene Set Enrichment Analysis across the signature of high- versus low-risk tumors from the HumanExon array show enrichment of neuronal and synapse part (D) and autism disorder predisposition genes (E). (F) Volcano plot showing differential expression between high- and low-risk highlighting genes with recurrent SVs and their functional classification. (G) Subtype-specific high- versus low-risk differential expression analysis of 77 recurrently altered genes from Figure 3I shown as scatter plot: (MNA) x-axis; (HR-NA) y-axis). (DG) Analysis was replicated in two data sets: HuEx arrays (here) and RNA-seq (Supplemental Fig. S21A–D).

This Article

  1. Genome Res. 30: 1228-1242

Preprint Server